Mast cells as a potential prognostic marker in prostate cancer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Despite years of intensive investigation that has been made in understanding prostate cancer, it remains one of the major mens health issues and the leading cause of deathworldwide. It is nowascertained that prostate cancer emerges frommultiple spontaneous and/or inherited alterations that induce changes in expression patterns of genes and proteins that function in complex networks controlling critical cellular events. It is nowaccepted that several innate and adaptiveimmune cells, including T- and B-lymphocytes, macrophages, natural killer cells, dendritic cells, neutrophils, eosinophils, and mast cells (MCs), infiltrate the prostate cancer. All of these cells are irregularly scattered within the tumor and loaded with an assorted array of cytokines, chemokines, and inflammatory and cytotoxic mediators. This complex framework reflects the diversity in tumor biology and tumor-host interactions.MCs arewellestablished effector cells in Immunoglobulin-E (Ig-E) associated immune responses and potent effector cells of the innate immune system; however, their clinical significance in prostate cancer is still debated. Here, these controversies are summarized, focusing on the implications of these findings in understanding the roles of MCs in primary prostate cancer.

Original languageEnglish
Pages (from-to)711-720
Number of pages10
JournalDisease Markers
Volume35
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Mast Cells
Tumors
Prostatic Neoplasms
Lymphocytes
Macrophages
Immune system
Complex networks
Chemokines
Immunoglobulin E
Men's Health
Neoplasms
Cytokines
Eosinophils
Natural Killer Cells
Dendritic Cells
Immune System
Neutrophils
B-Lymphocytes
Proteins

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Mast cells as a potential prognostic marker in prostate cancer. / Taverna, Gianluigi; Giusti, Guido; Seveso, Mauro; Hurle, Rodolfo; Colombo, Piergiuseppe; Stifter, Sanja; Grizzi, Fabio.

In: Disease Markers, Vol. 35, No. 6, 2013, p. 711-720.

Research output: Contribution to journalArticle

@article{10ed4dbaf2fa4aee940bb8ac08cd16e7,
title = "Mast cells as a potential prognostic marker in prostate cancer",
abstract = "Despite years of intensive investigation that has been made in understanding prostate cancer, it remains one of the major mens health issues and the leading cause of deathworldwide. It is nowascertained that prostate cancer emerges frommultiple spontaneous and/or inherited alterations that induce changes in expression patterns of genes and proteins that function in complex networks controlling critical cellular events. It is nowaccepted that several innate and adaptiveimmune cells, including T- and B-lymphocytes, macrophages, natural killer cells, dendritic cells, neutrophils, eosinophils, and mast cells (MCs), infiltrate the prostate cancer. All of these cells are irregularly scattered within the tumor and loaded with an assorted array of cytokines, chemokines, and inflammatory and cytotoxic mediators. This complex framework reflects the diversity in tumor biology and tumor-host interactions.MCs arewellestablished effector cells in Immunoglobulin-E (Ig-E) associated immune responses and potent effector cells of the innate immune system; however, their clinical significance in prostate cancer is still debated. Here, these controversies are summarized, focusing on the implications of these findings in understanding the roles of MCs in primary prostate cancer.",
author = "Gianluigi Taverna and Guido Giusti and Mauro Seveso and Rodolfo Hurle and Piergiuseppe Colombo and Sanja Stifter and Fabio Grizzi",
year = "2013",
doi = "10.1155/2013/478303",
language = "English",
volume = "35",
pages = "711--720",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",
number = "6",

}

TY - JOUR

T1 - Mast cells as a potential prognostic marker in prostate cancer

AU - Taverna, Gianluigi

AU - Giusti, Guido

AU - Seveso, Mauro

AU - Hurle, Rodolfo

AU - Colombo, Piergiuseppe

AU - Stifter, Sanja

AU - Grizzi, Fabio

PY - 2013

Y1 - 2013

N2 - Despite years of intensive investigation that has been made in understanding prostate cancer, it remains one of the major mens health issues and the leading cause of deathworldwide. It is nowascertained that prostate cancer emerges frommultiple spontaneous and/or inherited alterations that induce changes in expression patterns of genes and proteins that function in complex networks controlling critical cellular events. It is nowaccepted that several innate and adaptiveimmune cells, including T- and B-lymphocytes, macrophages, natural killer cells, dendritic cells, neutrophils, eosinophils, and mast cells (MCs), infiltrate the prostate cancer. All of these cells are irregularly scattered within the tumor and loaded with an assorted array of cytokines, chemokines, and inflammatory and cytotoxic mediators. This complex framework reflects the diversity in tumor biology and tumor-host interactions.MCs arewellestablished effector cells in Immunoglobulin-E (Ig-E) associated immune responses and potent effector cells of the innate immune system; however, their clinical significance in prostate cancer is still debated. Here, these controversies are summarized, focusing on the implications of these findings in understanding the roles of MCs in primary prostate cancer.

AB - Despite years of intensive investigation that has been made in understanding prostate cancer, it remains one of the major mens health issues and the leading cause of deathworldwide. It is nowascertained that prostate cancer emerges frommultiple spontaneous and/or inherited alterations that induce changes in expression patterns of genes and proteins that function in complex networks controlling critical cellular events. It is nowaccepted that several innate and adaptiveimmune cells, including T- and B-lymphocytes, macrophages, natural killer cells, dendritic cells, neutrophils, eosinophils, and mast cells (MCs), infiltrate the prostate cancer. All of these cells are irregularly scattered within the tumor and loaded with an assorted array of cytokines, chemokines, and inflammatory and cytotoxic mediators. This complex framework reflects the diversity in tumor biology and tumor-host interactions.MCs arewellestablished effector cells in Immunoglobulin-E (Ig-E) associated immune responses and potent effector cells of the innate immune system; however, their clinical significance in prostate cancer is still debated. Here, these controversies are summarized, focusing on the implications of these findings in understanding the roles of MCs in primary prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=84896963753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896963753&partnerID=8YFLogxK

U2 - 10.1155/2013/478303

DO - 10.1155/2013/478303

M3 - Article

C2 - 24324287

AN - SCOPUS:84896963753

VL - 35

SP - 711

EP - 720

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

IS - 6

ER -